PATENT CLAIM ANALYSIS

Application Number: 15952682
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "210160"]

Abstract:
Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R 1 , R 2 , and R 3  are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Na v 1.7 and/or Na v 1.8. Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.

Claim (Index 27):
A method of treating a condition or disorder modulated by the voltage-gated sodium channels Na v 1.7 and/or Na v 1.8 in a mammal comprising administering an effective amount of [(3R)-3-fluoropyrrolidin-1-yl](6-{[5-(trifluoromethyl)pyridin-2-yl]oxy}quinolin-2-yl)methanone, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.66071
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15239554', '14613579', '14053682', '14053653', '11010236']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.689931322320439
- 35 USC 102 Novelty (BERT): 0.4778466715580431
- Combined Prediction Score: 0.6687228572441994
- Mean Citation Score: 146.720002
- Max Citation Score: 154.40837
- Similarity Product: 113.7126293017858

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test